RhoA protein is generally distributed in the nuclei of cancer cells

Oncology Reports

Volumn 24, Issue 4, 2010, Pages 1005-1009

  Li, Yueying ^a   Chen, Yongchang ^a   Tao, Yan ^a   Xu, Jin ^a   Chen, Miao ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Cancer cell; Cancer tissue; Distribution; Necrosis; Nuclear; RhoA

Indexed keywords

RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ACCURACY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOSOL; FEMALE; HELA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; NUCLEOLUS; PRIORITY JOURNAL; STOMACH CANCER; STOMACH EPITHELIUM; WESTERN BLOTTING;

EID: 77957362554     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000948     Document Type: Article

References (28)

1. Price LS and Collard JG: Regulation of the cytoskeleton by Rho-family GTPases: implications for tumour cell invasion. Semin Cancer Biol 11: 167-173, 2001.
2. Sotiropoulos A, Gineitis D, Copeland J and Treisman R: Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell 98: 159-169, 1999.
3. Kjoller L and Hall A: Signaling to Rho GTPases. Exp Cell Res 253: 166-179, 1999.
4. Narumiya S: The small GTPase Rho: cellular functions and signal transduction. Biochem 120: 215-228, 1996.
5. Yonemura S, Hirao-Minakuchi K and Nishimura Y: Rho localization in cells and tissues. Exp Cell Res 295: 300-314, 2004.
6. Hoffman GR, Nassar N and Cerione RA: Structure of the Rho family GTP binding protein Cdc42 in complex with the multifunctional regulator RhoGD I. Cell 100: 345-356, 2000.
7. Adamson P, Paterson HF and Hall A: Intracellular localization of the p21rho proteins. Cell Biol 119: 617-627, 1992.
8. Yan Tao, Yong-Chang Chen and Yue-Ying Li: Localization and translocation of RhoA protein in the human gastric cancer cell line SGC-7901. World J Gastroenterol 14: 1175-1181, 2008.
9. Chen JC, Zhuang S, Nguyen TH, Boss GR and Pilz RB: Oncogenic Ras leads to Rho activation by activating the mitogen-activated protein kinase pathway and decreasing Rho-GTPase-activating protein activity. Biol Chem 278: 2807-2818, 2003.
10. Pan Y, Bi F, Liu N, Xue Y, Yao X, Zheng Y and Fan D: Expression of seven main Rho family members in gastric carcinoma. BBRC 315: 686-691, 2004.
11. Raftopoulou M and Hall A: Cell migration: Rho GTPases lead the way. Dev Biol 265: 23-32, 2004.
12. Moore MS and Blogel G: The GTP-binding protein Ran/TC4 is required for protein import into the nucleus. Nature 365: 661-663, 1993.
13. Moore JD: The Ran-GTPase and cell-cycle control. Bioessays 23: 77-85, 2001.
14. Mitra RS, Zhang Z, Henson BS, Kurnit DM, Carey TE and D'Silva NJ: Rap1A and rap1B ras-family proteins are prominently expressed in the nucleus of squamous carcinomas: nuclear traslocation of GTP-bound active form. Oncogene 22: 6243-6256, 2003.
15. Wurzer G, Mosgoeller W, Chabicovsky M, Cerni C and Wesierska-Gadek J: Nuclear Ras: unexpected subcellular distribution of oncogenic forms. Cell Biochem (Suppl.) 36: 1-11, 2001.
16. Moroianu J: Molecular mechanisms of nuclear protein transport. Crit Rev Eukaryot Gene Expr 7: 61-72, 1997.
17. Friedrich B, Quensel C, Sommer T, Hartmann E and Köhler M: Nuclear localization signal and protein context both mediate importin alpha specificity of nuclear import substrates. Mol Cell Biol 26: 8697-8709, 2006.
18. Wei SJ, Botero A, Hirota K, et al: Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protor-1 transcription factor in response to ionizing radiation. Cancer Res 60: 6688-6695, 2000.
19. Tell G, Damante G, Caldwell D and Kelley MR: The intracellular localization of APE1/Ref-1: more than a passive phenomenon? Antioxid Redox Signal 7: 367-384, 2005.
20. Kakolyris S, Kaklamanis L, Giatromanolaki A, et al: Expression and subcellular localization of human AP endonuclease1 (HAP1/Ref-1) protein: a basis for its role in human disease. Histopathology 33: 561-569, 1998.
21. Pines A, Perrone L, Bivi N, et al: Activation of APE1/Ref-1is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP. Nucleic Acids Res 33: 4379-4394, 2005.
22. Bowler WB, Littlewood-Evans A, Bilbe G, Gallagher JA and Dixon CJ: P2Y2 receptors are expressed by human osteoclasts of giant cell tumor but do not mediate ATP-induced bone resorption. Bone 22: 195-200, 1998.
23. Ostrom RS, Gregorian C and Insel PA: Cellular release of and response to ATP as key determinants of the set-point of signal transduction pathways. Biol Chem 275: 11735-11739, 2000.
24. Shaw PJ, Ganey PE and Roth RA: Tumor necrosis factor alpha is a proximal mediator of synergistic hepatotoxicity from trovafloxacin/lipopolysaccharide coexposure. Pharmacol Exp Ther 328: 62-68, 2009.
25. Fiemu E, Nwariaku, Rothenbach P, Zhu X, Turnage RH and Terada LS: Rho inhibition decreases TNF-induced endothelial MAPK activation and monolayer permeability. Appl Physiol 95: 1889-1895, 2003.
26. Chae HJ, Chae SW, Chin HY, et al: The p38 mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumor necrosis factor in osteoblasts. Bone 28: 45-53, 2001.
27. Takaishi K, Matozaki T, Nakano K and Takai Y: Multiple downstream signalling pathways from ROCK, a target molecule of Rho small G protein, in reorganization of the actin cytoskeleton in Madin-Darby canine kidney cells. Genes Cells 5: 929-936, 2000.
28. Hippenstiel S, Soeth S, Kellas B, et al: Rho proteins and the p38-MAPK pathway are important mediators for LPS-induced interleukin-8 expression in human endothelial cells. Blood 95: 3044-3051, 2000.